Filed Regulatory Dossier For Approval Of Rizatriptan Orally Dissolving Film In Europe
07/07/2020 15:30
July 7 (Reuters) - Zim Laboratories Ltd ZIML.BO :
* ZIM LABORATORIES LTD - FILED REGULATORY DOSSIER FOR
APPROVAL OF
RIZATRIPTAN ORALLY DISSOLVING FILM IN EUROPE
Source text for Eikon: ID:nBSE7g8NZG
Further company coverage: ZIML.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia